{
  "nctId": "NCT02835274",
  "briefTitle": "Study to Characterize Acute and Chronic Directional Aspects of Deep Brain Stimulation",
  "officialTitle": "Directional Lead: Investigation of Rotational Current Steering, Ease of Use of Clinical Effects Map, and Therapeutic Outcomes of Deep Brain Stimulation",
  "protocolDocument": {
    "nctId": "NCT02835274",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2016-02-25",
    "uploadDate": "2020-01-27T11:33",
    "size": 638973,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02835274/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "CROSSOVER",
  "masking": "DOUBLE",
  "enrollmentInfo": {
    "enrollmentCount": 12,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2016-07-19",
    "completionDate": "2018-12-19",
    "primaryCompletionDate": "2018-12-19",
    "firstSubmitDate": "2016-06-24",
    "firstPostDate": "2016-07-18"
  },
  "eligibilityCriteria": {
    "criteria": "Key Inclusion Criteria:\n\n* Diagnosis of bilateral idiopathic PD with the presence of rigidity and at least one (1) of the following: resting tremor or bradykinesia.\n* UPDRS III score of \\>25 in the meds OFF condition\n* Medication must improve PD symptoms by â‰¥30%, as measured by UPDRS subset III score\n\nKey Exclusion Criteria:\n\n* Any significant psychiatric problems, including unrelated clinically significant depression as determined by the investigator\n* Any current drug or alcohol abuse as determined by the investigator\n* Any history of recurrent or unprovoked seizures\n* Any significant medical condition that is likely to interfere with study procedures or likely to confound evaluation of study endpoints, including any terminal illness with survival \\<12 months",
    "healthyVolunteers": false,
    "sex": "ALL",
    "stdAges": [
      "CHILD",
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Mean Change in Unified Parkinson's Disease Rating Scale (UPDRS) Scores - Motor Section (Part III) at End of Randomized Phase",
        "description": "Mean change in Unified Parkinson's Disease Rating Scale (UPDRS) scores - motor section (Part III) at end of randomized phase in meds ON condition\n\nRange of UPDRS III is 0 - 108 with greater scores indicating worse disease state",
        "timeFrame": "Up to 12 months post-implant"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 1
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "CROSSOVER"
    },
    "overallComplexityScore": 39,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:29:44.573Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}